标题
The NLRP3 Inflammasome and Its Role in the Pathogenicity of Leukemia
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 3, Pages 1271
出版商
MDPI AG
发表日期
2021-01-28
DOI
10.3390/ijms22031271
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The NLRP3 inflammasome: a therapeutic target for inflammation-associated cancers
- (2020) Mahdi Gouravani et al. Expert Review of Clinical Immunology
- Effect of P2X7 receptor on tumorigenesis and its pharmacological properties
- (2020) Wen-jun Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- The Nlrp3 inflammasome as a “rising star” in studies of normal and malignant hematopoiesis
- (2020) Mariusz Z. Ratajczak et al. LEUKEMIA
- Disulfiram/cytarabine eradicates a subset of acute myeloid leukemia stem cells with high aldehyde dehydrogenase expression
- (2020) Wanfang Yang et al. LEUKEMIA RESEARCH
- FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation
- (2020) Jun Jacob Hu et al. NATURE IMMUNOLOGY
- Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
- (2020) Shaima’a Hamarsheh et al. Nature Communications
- Focus on the Role of NLRP3 Inflammasome in Diseases
- (2020) Roberta Fusco et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Recent advances in the NEK7-licensed NLRP3 inflammasome activation: Mechanisms, role in diseases and related inhibitors
- (2020) Ni Zhao et al. JOURNAL OF AUTOIMMUNITY
- NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword
- (2020) Shaima'a Hamarsheh et al. Frontiers in Immunology
- Latest perspectives on glucocorticoid-induced apoptosis and resistance in lymphoid malignancies
- (2020) Dorien Clarisse et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Therapeutic Modulation of Autophagy in Leukaemia and Lymphoma
- (2019) Mojgan Djavaheri-Mergny et al. Cells
- Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
- (2019) Yang Yang et al. Cell Death & Disease
- Innate immunity, inflammation and tumour progression: double‐edged swords
- (2019) A. Mantovani et al. JOURNAL OF INTERNAL MEDICINE
- Chronic myeloid leukemia stem cells
- (2019) Mohammad Houshmand et al. LEUKEMIA
- MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition
- (2019) Rebecca C. Coll et al. Nature Chemical Biology
- MCC950 closes the active conformation of NLRP3 to an inactive state
- (2019) Ana Tapia-Abellán et al. Nature Chemical Biology
- RNA viruses promote activation of the NLRP3 inflammasome through cytopathogenic effect-induced potassium efflux
- (2019) Leandro Silva da Costa et al. Cell Death & Disease
- Chronic lymphocytic leukemia: 2019 update on diagnosis, risk stratification and treatment
- (2019) Michael Hallek AMERICAN JOURNAL OF HEMATOLOGY
- Inflammation and Cancer: Triggers, Mechanisms, and Consequences
- (2019) Florian R. Greten et al. IMMUNITY
- The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
- (2019) Nathan Kelley et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome
- (2019) Humayun Sharif et al. NATURE
- Chronic lymphocytic leukaemia: from genetics to treatment
- (2019) Francesc Bosch et al. Nature Reviews Clinical Oncology
- Investigation of NF-κB-94ins/del ATTG and CARD8 (rs2043211) Gene Polymorphism in Acute Lymphoblastic Leukemia
- (2019) Chen Zhang et al. Frontiers in Endocrinology
- Cellular senescence induced by S100A9 in mesenchymal stromal cells through NLRP3 inflammasome activation
- (2019) Lei Shi et al. Aging-US
- Inhibition of NLRP3 inflammasome in tumor microenvironment leads to suppression of metastatic potential of cancer cells
- (2019) Hye Eun Lee et al. Scientific Reports
- Pharmacological Inhibitors of the NLRP3 Inflammasome
- (2019) Ayesha Zahid et al. Frontiers in Immunology
- OLT1177 (Dapansutrile), a Selective NLRP3 Inflammasome Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis
- (2019) Alba Sánchez-Fernández et al. Frontiers in Immunology
- Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases
- (2019) Xiangna Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Disulfiram/copper causes ROS levels alteration, cell cycle inhibition, and apoptosis in acute myeloid leukaemia cell lines with modulation in the expression of related genes
- (2018) Saeed Hassani et al. BIOMEDICINE & PHARMACOTHERAPY
- Targeting autophagy in cancer
- (2018) Angelique V. Onorati et al. CANCER
- Tranilast directly targets NLRP3 to treat inflammasome‐driven diseases
- (2018) Yi Huang et al. EMBO Molecular Medicine
- The genetic polymorphism and expression profiles of NLRP3 inflammasome in patients with chronic myeloid leukemia
- (2018) Amin Zhang et al. HUMAN IMMUNOLOGY
- The TWIK2 Potassium Efflux Channel in Macrophages Mediates NLRP3 Inflammasome-Induced Inflammation
- (2018) Anke Di et al. IMMUNITY
- Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activity
- (2018) Dave Boucher et al. JOURNAL OF EXPERIMENTAL MEDICINE
- MCC950, the Selective Inhibitor of Nucleotide Oligomerization Domain-Like Receptor Protein-3 Inflammasome, Protects Mice against Traumatic Brain Injury
- (2018) Saifudeen Ismael et al. JOURNAL OF NEUROTRAUMA
- Inhibiting the NLRP3 Inflammasome Activation with MCC950 Ameliorates Diabetic Encephalopathy in db/db Mice
- (2018) Yadong Zhai et al. MOLECULES
- Mechanism of gasdermin D recognition by inflammatory caspases and their inhibition by a gasdermin D-derived peptide inhibitor
- (2018) Jie Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
- (2018) Carlo Marchetti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity
- (2018) Hongbin He et al. Nature Communications
- MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice
- (2018) Agampodi Promoda Perera et al. Scientific Reports
- The NLRP3-Caspase 1 Inflammasome Negatively Regulates Autophagy via TLR4-TRIF in Prion Peptide-Infected Microglia
- (2018) Mengyu Lai et al. Frontiers in Aging Neuroscience
- The Critical Role of Inflammation in the Pathogenesis and Progression of Myeloid Malignancies
- (2018) Brianna Craver et al. Cancers
- The cytokine network in acute myeloid leukemia (AML): A focus on pro- and anti-inflammatory mediators
- (2018) Stephanie Binder et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Interleukin-1 Beta—A Friend or Foe in Malignancies?
- (2018) Rebekka Bent et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Loss of the selective autophagy receptor p62 impairs murine myeloid leukemia progression and mitophagy
- (2018) The Duy Nguyen et al. BLOOD
- Nilotinib in the treatment of chronic myeloid leukemia
- (2018) Tomasz Sacha et al. Future Oncology
- What role does pyroptosis play in microbial infection?
- (2018) Xiaojing Xia et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice
- (2018) Richard Gordon et al. Science Translational Medicine
- NLRP3 lacking the leucine-rich repeat domain can be fully activated via the canonical inflammasome pathway
- (2018) Iva Hafner-Bratkovič et al. Nature Communications
- Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders
- (2017) Hua Jiang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
- (2017) Auvro R. Mridha et al. JOURNAL OF HEPATOLOGY
- Tumor-related interleukins: old validated targets for new anti-cancer drug development
- (2017) Sarra Setrerrahmane et al. Molecular Cancer
- The NLRP3 inflammasome in acute myocardial infarction
- (2017) Stefano Toldo et al. Nature Reviews Cardiology
- Aberrant NLRP3 inflammasome associated with aryl hydrocarbon receptor potentially contributes to the imbalance of T‑helper cells in patients with acute myeloid leukemia
- (2017) Yan Jia et al. Oncology Letters
- CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activation
- (2017) Tiantian Tang et al. Nature Communications
- Acute lymphoblastic leukemia: a comprehensive review and 2017 update
- (2017) T Terwilliger et al. Blood Cancer Journal
- Rapamycin regulates macrophage activation by inhibiting NLRP3 inflammasome-p38 MAPK-NFκB pathways in autophagy- and p62-dependent manners
- (2017) Jung Hwa Ko et al. Oncotarget
- Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia
- (2017) Alyssa Carey et al. Cell Reports
- Different Regulation of Interleukin-1 Production and Activity in Monocytes and Macrophages: Innate Memory as an Endogenous Mechanism of IL-1 Inhibition
- (2017) Mariusz P. Madej et al. Frontiers in Pharmacology
- Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation
- (2017) Carolina Pellegrini et al. Frontiers in Immunology
- Inflammatory Signaling Pathways in Preleukemic and Leukemic Stem Cells
- (2017) Shayda Hemmati et al. Frontiers in Oncology
- IL1RAP antibodies block IL-1-induced expansion of candidate CML stem cells and mediate cell killing in xenograft models
- (2016) H. Agerstam et al. BLOOD
- Inhibition of interleukin-1 signaling enhances elimination of tyrosine kinase inhibitor-treated CML stem cells
- (2016) B. Zhang et al. BLOOD
- The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype
- (2016) A. A. Basiorka et al. BLOOD
- Mitophagy: a balance regulator of NLRP3 inflammasome activation
- (2016) Min-Ji Kim et al. BMB Reports
- NF-κB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria
- (2016) Zhenyu Zhong et al. CELL
- Discovery and development of natural product oridonin-inspired anticancer agents
- (2016) Ye Ding et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Genetic polymorphisms of IL-18 rs1946518 and IL-1β rs16944 are associated with prognosis and survival of acute myeloid leukemia
- (2016) Hong Wang et al. INFLAMMATION RESEARCH
- The cell biology of inflammasomes: Mechanisms of inflammasome activation and regulation
- (2016) Deepika Sharma et al. JOURNAL OF CELL BIOLOGY
- Polymorphisms of Interlukin-1β rs16944 confer susceptibility to myelodysplastic syndromes
- (2016) Congcong Yin et al. LIFE SCIENCES
- Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores
- (2016) Xing Liu et al. NATURE
- NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux
- (2016) Yuan He et al. NATURE
- Strong inflammatory response and Th1-polarization profile in children with acute lymphoblastic leukemia without apparent infection
- (2016) E. PÉREZ-FIGUEROA et al. ONCOLOGY REPORTS
- Mechanism and Regulation of NLRP3 Inflammasome Activation
- (2016) Yuan He et al. TRENDS IN BIOCHEMICAL SCIENCES
- Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer’s disease in rodent models
- (2016) Michael J. D. Daniels et al. Nature Communications
- Effective elimination of adult B-lineage acute lymphoblastic leukemia by disulfiram/copper complex in vitro and in vivo in patient-derived xenograft models
- (2016) Manman Deng et al. Oncotarget
- Acute myeloid leukaemia
- (2016) Asim Khwaja et al. Nature Reviews Disease Primers
- Unraveling the Pathogenesis of MDS: The NLRP3 Inflammasome and Pyroptosis Drive the MDS Phenotype
- (2016) David A. Sallman et al. Frontiers in Oncology
- Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death
- (2016) Erica Salaro et al. Scientific Reports
- Oridonin triggers apoptosis in colorectal carcinoma cells and suppression of microRNA-32 expression augments oridonin-mediated apoptotic effects
- (2015) Jie Yang et al. BIOMEDICINE & PHARMACOTHERAPY
- The inflammasome: firing up innate immunity
- (2015) Thirumala-Devi Kanneganti IMMUNOLOGICAL REVIEWS
- A Genome-wide CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Screen Identifies NEK7 as an Essential Component of NLRP3 Inflammasome Activation
- (2015) Jonathan L. Schmid-Burgk et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- K+Efflux Agonists Induce NLRP3 Inflammasome Activation Independently of Ca2+Signaling
- (2015) Michael A. Katsnelson et al. JOURNAL OF IMMUNOLOGY
- Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling
- (2015) Nobuhiko Kayagaki et al. NATURE
- Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
- (2015) Jianjin Shi et al. NATURE
- NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells
- (2015) Steven W Paugh et al. NATURE GENETICS
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Acute Myeloid Leukemia
- (2015) Hartmut Döhner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tranilast: A review of its therapeutic applications
- (2015) Sara Darakhshan et al. PHARMACOLOGICAL RESEARCH
- Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia
- (2015) Helena Ågerstam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bone Marrow Cells in Acute Lymphoblastic Leukemia Create a Proinflammatory Microenvironment Influencing Normal Hematopoietic Differentiation Fates
- (2015) Armando Vilchis-Ordoñez et al. Biomed Research International
- Caspase-1 Cleavage of the TLR Adaptor TRIF Inhibits Autophagy and β-Interferon Production during Pseudomonas aeruginosa Infection
- (2014) Majid Sakhi Jabir et al. Cell Host & Microbe
- Lysosomes Integrate Metabolic-Inflammatory Cross-talk in Primary Macrophage Inflammasome Activation
- (2014) Kassandra Weber et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Disulfiram targeting lymphoid malignant cell lines via ROS-JNK activation as well as Nrf2 and NF-kB pathway inhibition
- (2014) Jie Zha et al. Journal of Translational Medicine
- Intracellular Glutathione Depletion by Oridonin Leads to Apoptosis in Hepatic Stellate Cells
- (2014) Liang-Mou Kuo et al. MOLECULES
- Calcium signaling and mitochondrial destabilization in the triggering of the NLRP3 inflammasome
- (2014) Tiffany Horng TRENDS IN IMMUNOLOGY
- Chronic Inflammation and Cytokines in the Tumor Microenvironment
- (2014) Glauben Landskron et al. Journal of Immunology Research
- Selective killing of candidate AML stem cells by antibody targeting of IL1RAP
- (2013) M. Askmyr et al. BLOOD
- K+ Efflux Is the Common Trigger of NLRP3 Inflammasome Activation by Bacterial Toxins and Particulate Matter
- (2013) Raúl Muñoz-Planillo et al. IMMUNITY
- The Interleukin-1 Family: Back to the Future
- (2013) Cecilia Garlanda et al. IMMUNITY
- Oxidized Mitochondrial DNA Activates the NLRP3 Inflammasome during Apoptosis
- (2012) Kenichi Shimada et al. IMMUNITY
- Multiple Binding Sites on the Pyrin Domain of ASC Protein Allow Self-association and Interaction with NLRP3 Protein
- (2012) Parimala R. Vajjhala et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction
- (2012) Chong-Shan Shi et al. NATURE IMMUNOLOGY
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
- (2012) Charles A. Dinarello et al. NATURE REVIEWS DRUG DISCOVERY
- Critical role for calcium mobilization in activation of the NLRP3 inflammasome
- (2012) T. Murakami et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Disulfiram/copper complex activated JNK/c-jun pathway and sensitized cytotoxicity of doxorubicin in doxorubicin resistant leukemia HL60 cells
- (2011) Bing Xu et al. BLOOD CELLS MOLECULES AND DISEASES
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Canakinumab
- (2010) Eugen Dhimolea mAbs
- A role for mitochondria in NLRP3 inflammasome activation
- (2010) Rongbin Zhou et al. NATURE
- Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome
- (2010) Kiichi Nakahira et al. NATURE IMMUNOLOGY
- Mechanisms of mitophagy
- (2010) Richard J. Youle et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Cutting Edge: TNF- Mediates Sensitization to ATP and Silica via the NLRP3 Inflammasome in the Absence of Microbial Stimulation
- (2009) L. Franchi et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: NF- B Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
- (2009) F. G. Bauernfeind et al. JOURNAL OF IMMUNOLOGY
- Differential requirement for the activation of the inflammasome for processing and release of IL-1 in monocytes and macrophages
- (2008) M. G. Netea et al. BLOOD
- Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia
- (2008) Maria G. Ennas et al. HEMATOLOGICAL ONCOLOGY
- Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production
- (2008) Tatsuya Saitoh et al. NATURE
- IL-1 trap go-ahead
- (2008) Mark Ratner NATURE BIOTECHNOLOGY
- Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
- (2008) Veit Hornung et al. NATURE IMMUNOLOGY
- ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1 and IL-18 secretion in an autocrine way
- (2008) A. Piccini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation